Q32 Bio, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US7469641051
USD
6.91
0.92 (15.36%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
53.74
0.00
0.00
0.00
0.00
0.00
0.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
53.74
0.00
0.00
0.00
0.00
0.00
0.00
Raw Material Cost
0.09
0.09
0.09
0.12
0.12
0.12
0.12
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.20
0.30
0.30
0.30
0.00
0.30
1.70
Selling and Distribution Expenses
4.45
3.93
3.92
4.99
3.86
4.34
4.39
Other Expenses
0.31
0.33
0.49
0.68
1.05
1.40
1.17
Total Expenditure (Excl Depreciation)
7.86
7.58
9.17
12.23
14.53
18.81
17.92
Operating Profit (PBDIT) excl Other Income
45.9
-7.6
-9.200000000000001
-12.2
-14.5
-18.799999999999997
-17.9
Other Income
12.05
0.49
0.58
3.00
0.56
1.20
4.09
Operating Profit (PBDIT)
58.02
-7.00
-8.50
-9.11
-13.85
-17.49
-13.71
Interest
0.20
0.30
0.30
0.30
0.00
0.30
1.70
Exceptional Items
0.00
0.00
-0.60
-1.50
-0.20
0.32
0.00
Gross Profit (PBDT)
53.65
-0.09
-0.09
-0.12
-0.12
-0.12
-0.12
Depreciation
0.09
0.09
0.09
0.12
0.12
0.12
0.12
Profit Before Tax
57.73
-7.39
-9.49
-11.03
-14.17
-17.59
-15.53
Tax
0.00
0.00
0.00
0.00
0.02
0.00
0.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
57.73
-7.39
-9.49
-11.03
-14.19
-17.59
-16.98
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
57.73
-7.39
-9.49
-11.03
-14.19
-17.59
-16.98
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
57.73
-7.39
-9.49
-11.03
-14.19
-17.59
-16.98
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
42.01
-18.45
-12.23
-4.01
5.67
18.30
33.51
Earnings per share (EPS)
4.58
-0.6
-0.78
-0.9
-1.16
-1.46
-1.42
Diluted Earnings per share
4.58
-0.6
-0.78
-0.9
-1.16
-1.46
-1.42
Operating Profit Margin (Excl OI)
85.38%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Gross Profit Margin
107.6%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
PAT Margin
107.43%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Dec 2025 is 0.00% vs 0.00% in Sep 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Dec 2025 is 879.73% vs 22.11% in Sep 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Dec 2025 is 713.33% vs 17.58% in Sep 2025

stock-summary

Interest

QoQ Growth in quarter ended Dec 2025 is -33.33% vs 0.00% in Sep 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

Compare Quarterly Results Of Q32 Bio, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
53.74
0
53.74
Other Operating Income
0.00
0.00
0.00
Total Operating income
53.74
0
53.74
Raw Material Cost
0.09
0
0.09
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.20
0
0.20
Selling and Distribution Expenses
4.45
0
4.45
Other Expenses
0.31
0.00
0.31
Total Expenditure (Excl Depreciation)
7.86
0
7.86
Operating Profit (PBDIT) excl Other Income
45.88
0.00
45.88
Other Income
12.05
0
12.05
Operating Profit (PBDIT)
58.02
0
58.02
Interest
0.20
0
0.20
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
53.65
0
53.65
Depreciation
0.09
0
0.09
Profit Before Tax
57.73
0
57.73
Tax
0.00
0
0.00
Provisions and contingencies
0
0
0.00
Profit After Tax
57.73
0
57.73
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
57.73
0
57.73
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
57.73
0
57.73
Equity Capital
0
0
0.00
Face Value
0.00
0
0.00
Reserves
42.01
0
42.01
Earnings per share (EPS)
4.58
0
4.58
Diluted Earnings per share
4.58
0
4.58
Operating Profit Margin (Excl OI)
85.38%
0%
0.00
85.38%
Gross Profit Margin
107.60%
0%
0.00
107.60%
PAT Margin
107.43%
0%
0.00
107.43%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 5.37 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 0.00% vs 0.00% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 0.00% vs 100.00% in Dec 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 5.77 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 879.73% vs 22.11% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 506.34% vs 47.60% in Dec 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 4.60 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 713.33% vs 17.58% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 419.44% vs 43.97% in Dec 2024

Quarterly - Interest
Interest 0.02 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is -33.33% vs 0.00% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 0.00% vs -100.00% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 85.38%
in Dec 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024